Abstract
Background
Ochratoxin A (OTA) is a mycotoxin present in food that can be found in human blood, due to its long half-life. Plasma OTA detection represents a good parameter for evaluating the exposure at the population level.
Purpose
The relation between plasma OTA levels, dietary habits, and specific disease risk biomarkers (body mass index (BMI), C-reactive protein (CRP), and cardiovascular risk score) was investigated.
Methods
The study involved 327 subjects (150 men and 177 women) aged between 38 and 48 years. Food consumption was evaluated by means of the EPIC questionnaire; plasma OTA was measured by HPLC; CRP was determined in fresh serum samples by a latex particle-enhanced immunoturbidimetric assay.
Results
OTA was detected in 99.1% of plasma samples (LOD 25 ng/L); the mean ± SD value was 0.229 ± 0.238 ng/mL. However, only 5.2% of samples exceeded 500 ng/L, considered the threshold for a possible pathogenic activity. The estimated mean daily dietary intake of OTA resulted 0.452 ± 0.468 ng/kg body weight (bw)/day, markedly lower than the tolerable daily intake set by EFSA (17.1 ng/kg bw/day). Processed and mutton/lamb meat were found to contribute most to plasma OTA variance. Nevertheless, cereals, wine, beer, and jam/honey consumption correlated positively with OTA levels. Plasma OTA showed a significant positive association with CRP and cardiovascular risk score (β = 0.20 ± 0.08; P = 0.015 and β = 0.25 ± 0.08; P = 0.001, respectively); however, the association was present in men but not in women.
Conclusions
Even if the hypothesis of a possible hepatic toxicity of OTA in humans is yet to be verified, the positive association between plasma OTA and CRP may indicate a possible role of OTA in inflammation status and consequently in the genesis of cardiovascular diseases and cancer.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- bw:
-
Body weight
- CRP:
-
C-reactive protein
- CVD:
-
Cardiovascular disease
- OTA:
-
Ochratoxin A
- LOD:
-
Limit of detection
- LOQ:
-
Limit of quantification
- ROS:
-
Reactive oxygen species
- RSD:
-
Relative standard deviation
- TWI:
-
Tolerable weekly intake
References
Battilani P, Pietri A, Bertuzzi T, Languasco L, Giorni P, Kozakiewicz Z (2003) Occurrence of ochratoxin A producing fungi in grape grown in Italy. J Food Prot 66:633–636
IARC (1993) IARC Monographs on the evaluation of carcinogenic risks to humans, some naturally occurring substances, Food Items and constituents, Heterocyclic aromatic amines and mycotoxins, vol 56. IARC Publications, Lyon
EFSA (2006) Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to ochratoxin A in food. EFSA J 365: 1–56. http://www.efsa.europa.eu/en/scdocs/doc/contam_op_ej365_ochratoxin_a_food_en.pdf. Accessed 3 May 2011
Okutan H, Aydin G, Ozcelik N (2004) Protective role of melatonin in ochratoxin A toxicity in rat heart and lung. J Appl Toxicol 24:505–512
Galvano F, Ritieni A, Piva G, Pietri A (2005) Mycotoxins in the human food chain. In: Duarte-Diaz DE (ed) The mycotoxin blue book. Nottingham University Press, Nottingham, pp 187–224
Pfohl-leszkowicz A, Manderville RA (2007) Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 51:61–99
FAO/WHO, Food and Agriculture Organisation/World Health Organisation (2001) Ochratoxin A. In: Safety evaluation of certain mycotoxins in food, Prepared by the 56th Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series 47. World Health Organisation, Geneva, pp 281–387
European Commission (2008) RASFF The Rapid Alert System for Food and Feed. Annual report. http://ec.europa.eu/food/food/rapidalert/report2008_en.pdf. Accessed 3 May 2011
Studer-Rohr I, Schlatter J, Dietrich DR (2000) Kinetic parameters and intra-individual fluctuations of ochratoxin A plasma levels in humans. Arch Toxicol 74:499–510
Scott PM (2005) Biomarkers of human exposure to ochratoxin A. Food Addit Contam 22:99–107
Galvano F, Pietri A, Bertuzzi T, Gagliardi L, Ciotti S, Luisi S, Bognanno M, La Fauci L, Iacopino AM, Nigro F, Li Volti G, Vanella L, Giammanco G, Tina GL, Gazzolo D (2008) Maternal dietary habits and mycotoxins occurrence in mature human milk. Mol Nutr Food Res 52:496–501
Turconi G, Guarcello M, Livieri C, Comizzoli S, Maccarini L, Castellazzi AM, Pietri A, Piva G, Roggi C (2004) Evaluation of xenobiotics in human milk and ingestion by the newborn-an epidemiological survey in Lombardy (Northern Italy). Eur J Nutr 43:191–197
Biasucci G, Calabrese G, Di Giuseppe R, Carrara G, Colombo F, Mandelli B, Maj M, Bertuzzi T, Pietri A, Rossi F (2010) The presence of ochratoxin A in cord serum and in human milk and its correspondence with maternal dietary habits. Eur J Nutr 50:211–218
Muñoz K, Blaszkewicz M, Degen GH (2010) Simultaneous analysis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxin. J Chromatogr B Anal Technol Biomed Life Sci 878:2623–2629
Iacoviello L, Bonanni A, Costanzo S, De Curtis A, Di Castelnuovo A, Olivieri M, Zito F, Donati MB, de Gaetano G on behalf of the Moli-sani Project Investigators (2007) The Moli-Sani Project, a randomized, prospective cohort study in the Molise region in Italy; design, rationale and objectives. Ital J Public Health 4:110–118
Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F (1995) Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol 26(1):S152–S160
Pala V, Sieri S, Palli D, Salvini S, Berrino F, Bellegotti M, Frasca G, Tumino R, Sacerdote C et al (2003) Diet in the Italian EPIC cohorts: presentation of data and methodological issues. Tumori 89:594–607
Centritto F, Iacoviello L, di Giuseppe R, De Curtis A, Costanzo S, Zito F, Grioni S, Sieri S, Donati MB, de Gaetano G, Di Castelnuovo A (2009) Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr Metab Cardiovasc Dis 19:697–706
Giampaoli S, Palmieri L, Chiodini P, Cesana G, Ferrario M, Panico S et al (2004) The global cardiovascular risk chart. Ital Heart J Suppl 5:177–185
AOAC International (2005) Official methods of analysis. In: 18th ed Gaithersburg, MD, 49.06.01, method 973.37
Willett W, Stampfer M (1998) Implications of total energy intake for epidemiologic analysis. In: Willett W (ed) Nutritional epidemiology, 2nd edn. Oxford University Press, New York, pp 273–301
Dallal GE (2005) The little handbook of statistical practice. Available from: http://www.StatisticalPractice.com. Accessed 3 May 2011
Pérez de Obanos A, Lopez de Cerain A, Jiménez AM, Gonzalez-Peñas E, Bello J (2001) Ochratoxin A in human plasma: new data of exposition in Spain. Rev Toxicol 18:19–23
Palli D, Miraglia M, Saieva C, Masala G, Cava E, Colatosti M, Corsi AM, Russo A, Brera C (1999) Serum levels of ochratoxin A in healthy adults in Tuscany: correlation with individual characteristics and between repeat measurements. Cancer Epidemiol Biomarkers Prev 8:265–269
Thuvander A, Paulsen JE, Axberg K, Johansson N, Vidnes A, Enghardt-Barbieri H, Trygg K, Lund-Larsen K, Jahrl S, Widenfalk A, Bosnes V, Alexandere J, Hult K, Olsen M (2001) Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol 39:1145–1151
Filali A, Betbeder AM, Baudrimont I, Benayada A, Soulaymani R, Creppy E (2002) Ochratoxin A in human plasma in Morocco: a preliminary survey. Hum Exp Toxicol 21:241
Assaf H, Betbeder AM, Creppy EE, Pallardy M, Azouri H (2004) Ochratoxin A levels in human plasma and foods in Lebanon. Hum Exp Toxicol 23:495–501
Zimmerli B, Dick R (1995) Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by high-performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: methodology and Swiss data. J Chromatogr B 666:85–99
Grosso F, Said S, Mabrouk I, Fremy JM, Castegnaro M, Jemmali M, Dragacci S (2003) New data on the occurrence of ochratoxin A in Human sera from patients affected or not by renal diseases in Tunisia. Food Chem Toxicol 41:1133–1140
Hassen W, Abid S, Achour A, Creppy E, Bacha H (2004) Ochratoxin A and β2-microglobulinuria in healthy individuals and in chronic interstitial nephropathy patients in the Centre of Tunisia: a hot spot of Ochratoxin exposure. Toxicology 199:185–193
Dinis AM, Lino CM, Pena AS (2007) Ochratoxin A in nephropathic patients from two cities of central zone in Portugal. J Pharm Biomed Anal 44:553–557
Directorate-General Health and Consumer Protection of the European Commission (2002) Assessment of dietary intake of Ochratoxin A by the population of EU Member States—Report of experts participating in Task 3.2.7. In: Miraglia M, Brera C (eds) Reports on tasks for scientific cooperation; http://ec.europa.eu/food/fs/scoop/index_en.html. Accessed 3 May 2011
Blank R, Rolfs JP, Sudekum KH, Frohlich AA, Marquardt RR, Wolffram S (2003) Effects of chronic ingestion of ochratoxin A on blood levels and excretion of the mycotoxin in sheep. J Agric Food Chem 51(23):6899–6905
Majerus R, Bresch H, Otteneder H (2000) Ochratoxin A in wines, fruit juices and seasonings. Arch Lebensmittelhyg 51(4/5):95–97
Galvano F, Piva A, Ritieni A, Galvano G (2001) Dietary strategies to counteract the effects of mycotoxins: a review. J Food Prot 64:120–131
Surai PF (2002) In: Natural antioxidant in avian nutrition and reproduction. Nottingham University Press, UK
Grosse Y, Chekir-Ghedira L, Huc A, Obrecht-Pflumio S, Dirheimer G, Bacha H, Pfohl-Leszkowicz A (1997) Retinol, ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice with the mycotoxins ochratoxin A and zearalenone. Cancer Lett 114:225–229
Baldi A, Losio MN, Cheli F, Rebucci R, Sangalli L, Fusi E, Bertasi B, Pavoni E, Carli S, Politis I (2004) Evaluation of the protective effects of alpha-tocopherol and retinol against ochratoxin a cytotoxicity. Br J Nutr 91(4):507–512
Nanri A, Moore MA, Kono S (2007) Impact of C-reactive protein on disease risk and its relation to dietary factors. Asian Pac J Cancer Prev 8(2):167–177
Soyöz M, Ozçelik N, Kilinç I, Altuntaş I (2004) The effects of ochratoxin A on lipid peroxidation and antioxidant enzymes: a protective role of melatonin. Cell Biol Toxicol 20(4):213–219
Gagliano N, Donne ID, Torri C, Migliori M, Grizzi F, Milzani A, Filippi C, Annoni G, Colombo P, Costa F, Ceva-Grimaldi G, Bertelli AA, Giovannini L, Gioia M (2006) Early cytotoxic effects of ochratoxin A in rat liver: a morphological, biochemical and molecular study. Toxicology 225(2–3):214–224
Hundhausen C, Bösch-Saadatmandi C, Augustin K, Blank R, Wolffram S, Rimbach G (2005) Effect of vitamin E and polyphenols on ochratoxin A-induced cytotoxicity in liver (HepG2) cells. J Plant Physiol 162(7):818–822
El Golli Bennour E, Rodriguez-Enfedaque A, Bouaziz C, Ladjimi M, Renaud F, Bacha H (2009) Toxicities induced in cultured human hepatocarcinoma cells exposed to ochratoxin A: oxidative stress and apoptosis status. J Biochem Mol Toxicol 23(2):87–96
Petkova-Bocharova T, Chernozemsky IN, Castegnaro M (2002) Balkan endemic nephropathy and associate durinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Add Contam 19:282–302
Arlt VM, Ferluga D, Stiborova M, Pfohl-Leszkowicz A, Vukelic M, Ceovic S, Schmeiser HH, Cosyns JP (2002) Is aristolochic acid a risk factor for Balkan endemic nephropthy-associated urothelial cancer ? Int J Cancer 101:500–502
Suzuki S, Moroi K, Kanisawa M, Satoh T (1986) Effects of drug metabolizing enzyme inducers on carcinogenesis and toxicity of ochratoxin A in mice. Toxicol Lett 31(Suppl.):206
Kanisawa M, Suzuki S (1978) Induction of renal and hepatic tumors in mice by ochratoxin A; a mycotoxin. Gann 69:599–600
Heikkilä K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J, Ben-Shlomo Y, Ebrahim S, Lawlor DA (2009) Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Cause Control 20(1):15–26
Trichopoulus D, Psaltopoulou T, Orfanos P, Trichopoulou A, Boffetta P (2006) Plasma C-reactive protein and risk cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev 15(2):381–384
Allin KH, Nordestgaard BG, Zacho J, Tybjaerg-Hansen A, Bojesen SE (2010) C-reactive protein and the risk of cancer: a mendelian randomization study. J Natl Cancer Inst 102(3):202–206
Hussein AA, Arbid MS (2002) Circulatory disorders induced by ochratoxin A. Egyptian J Biol 4:147–156
Acknowledgments
This work was supported by Fondazione Romeo ed Enrica Invernizzi, Milano, Italia.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
See Table 5.
Rights and permissions
About this article
Cite this article
di Giuseppe, R., Bertuzzi, T., Rossi, F. et al. Plasma ochratoxin A levels, food consumption, and risk biomarkers of a representative sample of men and women from the Molise region in Italy. Eur J Nutr 51, 851–860 (2012). https://doi.org/10.1007/s00394-011-0265-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-011-0265-5